Concepedia

Martin Vanderlaan

MV

59

Publications

3.8K

Citations

32

H-Index

1975

Active since

Affiliations

Lawrence Livermore National Laboratory(Current)

University of California, San Francisco

Genentech

Martin Vanderlaan is an author at Lawrence Livermore National Laboratory specializing in medicine, bioanalysis, and biochemistry.

ORCID

Top concepts

Publications per year

1975–2019

59

Publications

59

Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle

Pekka Kurki, Martin Vanderlaan, Frank Dolbeare et al. · Experimental Cell Research · 1986 · 527 citations

, , +6

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

Yaning Wang, David Fei, Martin Vanderlaan et al. · Angiogenesis · 2004 · 432 citations

, , +8

One-step purification of mouse monoclonal antibodies from ascites fluid by hydroxylapatite chromatography

Larry H. Stanker, Martin Vanderlaan, Hector Juarez-Salinas · Journal of Immunological Methods · 1985 · 193 citations

, , +9

Cytochemistry for bromodeoxyuridine/DNA analysis: Stoichiometry and sensitivity

Frank Dolbeare, Wolfgang Beisker, Maria G. Pallavicini et al. · Cytometry · 1985 · 147 citations

Effect of carcinogens on chicken atherosclerosis.

Roy E. Albert, Martin Vanderlaan, Fredric J. Burns et al. · PubMed · 1977 · 127 citations

, , +11

Rows per page

1–5 of 59